Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives
- 1 July 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (13), 3711-3721
- https://doi.org/10.1016/j.bmc.2004.04.013
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxideBioorganic & Medicinal Chemistry, 2001
- New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agentsEuropean Journal of Medicinal Chemistry, 2000
- 4-Cyano-2-oxo-1,2,4-oxadiazolo[2,3-a]quinoxaline 5-N-oxides. New synthetic method and reaction with alcohols. Potential cytotoxic activityJournal of Heterocyclic Chemistry, 1996
- Evaluation of Anchorage-Independent Proliferation in Tumorigenic Cells Using the Redox Dye alamarBlue TMBioTechniques, 1996
- Hypoxia-Selective Agents Derived from 2-Quinoxalinecarbonitrile 1,4-Di-N-oxides. 2Journal of Medicinal Chemistry, 1995
- New hypoxia‐selective cytotoxines derived from quinoxaline 1,4‐dioxidesJournal of Heterocyclic Chemistry, 1995
- Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxidesJournal of Medicinal Chemistry, 1995
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- Personal ViewBMJ, 1969